BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21204803)

  • 21. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
    Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing for Lynch syndrome in the province of Ontario.
    Wang M; Aldubayan S; Connor AA; Wong B; Mcnamara K; Khan T; Semotiuk K; Khalouei S; Holter S; Aronson M; Cohen Z; Gallinger S; Charames G; Pollett A; Lerner-Ellis J
    Cancer; 2016 Jun; 122(11):1672-9. PubMed ID: 27019099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lynch syndrome in young-onset colorectal cancer: reassessing the role of the MSH6 gene.
    Giráldez MD; Castells A; Castellví-Bel S
    Clin Gastroenterol Hepatol; 2011 Sep; 9(9):806. PubMed ID: 21515405
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
    Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
    Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of Lynch syndrome in British Columbia.
    Cremin CM; Armstrong L; Gill S; Huntsman D; Bajdik C
    Can J Gastroenterol; 2009 Nov; 23(11):761-7. PubMed ID: 19893772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of pancreatic cancer in families with Lynch syndrome.
    Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
    JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
    Watson P; Vasen HFA; Mecklin JP; Bernstein I; Aarnio M; Järvinen HJ; Myrhøj T; Sunde L; Wijnen JT; Lynch HT
    Int J Cancer; 2008 Jul; 123(2):444-449. PubMed ID: 18398828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
    Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.
    Limburg PJ; Harmsen WS; Chen HH; Gallinger S; Haile RW; Baron JA; Casey G; Woods MO; Thibodeau SN; Lindor NM
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):497-502. PubMed ID: 21056691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
    Hampel H
    J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding hereditary colorectal cancer.
    Boland CR
    N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
    Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
    JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
    Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
    Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome.
    Lecomte T; Cellier C; Meatchi T; Barbier JP; Cugnenc PH; Jian R; Laurent-Puig P; Landi B
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):897-902. PubMed ID: 16234028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
    Rahner N; Steinke V; Schlegelberger B; Olschwang S; Eisinger F; Hutter P
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20104243
    [No Abstract]   [Full Text] [Related]  

  • 38. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid development of colorectal neoplasia in patients with Lynch syndrome.
    Edelstein DL; Axilbund J; Baxter M; Hylind LM; Romans K; Griffin CA; Cruz-Correa M; Giardiello FM
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):340-3. PubMed ID: 21070872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.